Development of a rapid agglutination latex test for diagnosis of enteropathogenic and enterohemorrhagic Escherichia coli infection in developing world: defining the biomarker, antibody and method

PLoS Negl Trop Dis. 2014 Sep 25;8(9):e3150. doi: 10.1371/journal.pntd.0003150. eCollection 2014 Sep.

Abstract

Background: Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC/EHEC) are human intestinal pathogens responsible for diarrhea in both developing and industrialized countries. In research laboratories, EPEC and EHEC are defined on the basis of their pathogenic features; nevertheless, their identification in routine laboratories is expensive and laborious. Therefore, the aim of the present work was to develop a rapid and simple assay for EPEC/EHEC detection. Accordingly, the EPEC/EHEC-secreted proteins EspA and EspB were chosen as target antigens.

Methodology: First, we investigated the ideal conditions for EspA/EspB production/secretion by ELISA in a collection of EPEC/EHEC strains after cultivating bacterial isolates in Dulbecco's modified Eagle's medium (DMEM) or DMEM containing 1% tryptone or HEp-2 cells-preconditioned DMEM, employing either anti-EspA/anti-EspB polyclonal or monoclonal antibodies developed and characterized herein. Subsequently, a rapid agglutination latex test (RALT) was developed and tested with the same collection of bacterial isolates.

Principal findings: EspB was defined as a biomarker and its corresponding monoclonal antibody as the tool for EPEC/EHEC diagnosis; the production of EspB was better in DMEM medium. RALT assay has the sensitivity and specificity required for high-impact diagnosis of neglected diseases in the developing world.

Conclusion: RALT assay described herein can be considered an alternative assay for diarrhea diagnosis in low-income countries since it achieved 97% sensitivity, 98% specificity and 97% efficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Bacterial / analysis
  • Bacterial Typing Techniques / methods*
  • Biomarkers / analysis
  • Developing Countries
  • Escherichia coli / isolation & purification*
  • Escherichia coli Infections / diagnosis*
  • Escherichia coli Infections / microbiology
  • Escherichia coli Proteins / analysis*
  • Humans
  • Latex Fixation Tests / methods*

Substances

  • Antibodies, Bacterial
  • Biomarkers
  • Escherichia coli Proteins

Grants and funding

This work was supported by grants 09/14845-7 from São Paulo Research Foundation (FAPESP) and from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq – 304033/2010-3) to RMFP. LBR (FAPESP - 07/58610-8), ARRS (FAPESP - 12/02618-9) and DEL were recipients of FAPESP fellowships and DDM and LTAC were recipients of CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.